New research has shown that using anti-inflammatory drugs and steroids to treat pain could increase the chances of developing chronic pain after a few years. These findings raise questions about the use of anti-inflammatories and steroids to alleviate pain.
A new experimental compound has shown promise in reducing uncontrolled, erratic muscle movements, called dyskinesia, associated with Parkinson’s disease. In animal studies, the compound reduced dyskinesia by 85%, a common side effect of levodopa used in Parkinson’s patients.
The FDA approved the use of InVisionOS, a virtual reality (VR) surgical planning tool, in November, which will be available early next year. The tool, developed by Canadian-based PrecisionOS, allows surgeons to plan operations using VR.
Scientists at Washington University School of Medicine in St. Louis have developed an ultrashort-pulse laser that can kill multi-drug resistant bacteria, without causing any harm to human cells. The laser could also decontaminate wounds and blood products.
A new study has found that specialized MRI scans detected old brain injuries in former American football players. The brain scans revealed signs of white matter injury, which could further help diagnose neurodegenerative diseases. This type of scan needs more studies to use as a diagnostic tool.
Purdue University and the National Institutes of Health (NIH) researchers have explained a possible mechanism of how vitamin D functions to reduce inflammation caused by the immune cells or T cells. Their findings could pave the way to develop new and effective treatments.
Baxter Asia Pacific has announced the launch of the online resource portal called My Kidney Journal to support patients with chronic kidney disease (CKD) in Indonesia. The website contains detailed information on CKD symptoms, causes, stages, multiple treatment options, etc.